Modular Medical, Inc. (NASDAQ:MODD – Get Free Report) CEO Manchester Management Co Llc bought 10,000 shares of the firm’s stock in a transaction on Thursday, November 19th. The shares were bought at an average price of $2.03 per share, for a total transaction of $20,300.00. Following the completion of the transaction, the chief executive officer directly owned 24,067 shares in the company, valued at approximately $48,856.01. This represents a 71.09% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available through this link.
Modular Medical Stock Performance
Shares of NASDAQ:MODD traded up $0.08 on Thursday, reaching $1.90. 131,965 shares of the company were exchanged, compared to its average volume of 99,140. Modular Medical, Inc. has a 1-year low of $1.20 and a 1-year high of $16.20. The company has a 50-day moving average of $2.04 and a 200-day moving average of $4.49.
Modular Medical (NASDAQ:MODD – Get Free Report) last announced its quarterly earnings results on Monday, November 16th. The company reported ($0.90) earnings per share (EPS) for the quarter.
Analysts Set New Price Targets
Check Out Our Latest Research Report on Modular Medical
Institutional Trading of Modular Medical
An institutional investor recently raised its stake in Modular Medical stock. AWM Investment Company Inc. boosted its position in shares of Modular Medical, Inc. (NASDAQ:MODD – Free Report) by 20.3% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 441,095 shares of the company’s stock after purchasing an additional 74,429 shares during the quarter. AWM Investment Company Inc. owned approximately 7.38% of Modular Medical worth $1,985,000 at the end of the most recent reporting period. 27.47% of the stock is owned by hedge funds and other institutional investors.
Modular Medical Company Profile
Modular Medical, Inc. is a medical-device company focused on developing insulin-delivery technology for people with diabetes. Its work centers on making pump therapy simpler and more accessible for people who may find traditional insulin pumps difficult to use. The company’s lead product, MODD1, is a wearable insulin-delivery system designed to provide an alternative to multiple daily insulin injections. Modular Medical describes the device as a simplified pump intended to make insulin delivery easier to manage.
Recommended Stories
- Five stocks we like better than Modular Medical
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Modular Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Modular Medical and related companies with MarketBeat.com's FREE daily email newsletter.
